Stocklytics Platform
Asset logo for symbol EW
Edwards Lifesciences
EW67
$71.47arrow_drop_up0.04%$0.03
S&P500
Asset logo for symbol EW
EW67

$71.47

arrow_drop_up0.04%
Key Stats
Open$71.60
Prev. Close$71.53
EPS2.59
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range71.29
72.45
52 Week Range58.93
96.12
Ratios
EPS2.59
Fundamentals
Payout Ratio-
Industry average yield2.72%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

EW-
US Healthcare Sector-
US Market-
check_circle

EW / Market

EW exceeded the US Market which returned -0.63% over the last twenty four hours.
warning

EW / Healthcare Sector

EW lose to the US Healthcare sector which returned 2.68% over the last twenty four hours.

Edwards Lifesciences (EW) Statistics

Edwards Lifesciences Corp (EW) is a leading medical technology company that specializes in innovative solutions for structural heart disease and critical care monitoring. The company is known for its expertise in heart valve replacement and repair, as well as minimally invasive surgical procedures. With a market capitalization of over $50 billion, EW is recognized as one of the largest players in the cardiovascular space.
When it comes to statistics, Edwards Lifesciences Corp has an impressive track record. The company has consistently outperformed its sector and delivered strong financial results year after year. In terms of valuation metrics, EW boasts a favorable price-to-earnings ratio and a healthy return on equity. These numbers indicate that investors have confidence in the company's ability to generate profits and create value.
add Edwards Lifesciences to watchlist

Keep an eye on Edwards Lifesciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Edwards Lifesciences (EW) stock's performance compared to its sector and the market over the past year?

Over the past year, Edwards Lifesciences (EW) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 30.78%, Edwards Lifesciences has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 60.01%, it has fallen short of the market average. This comparison highlights Edwards Lifesciences's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Edwards Lifesciences (EW) stock?

The PE (Price to Earnings) ratio of Edwards Lifesciences (EW) is currently 27.6. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Edwards Lifesciences (EW) stock?

The Earnings Per Share (EPS) for Edwards Lifesciences (EW), calculated on a diluted basis, is $2.59. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Edwards Lifesciences (EW) stock?

The operating margin for Edwards Lifesciences (EW) is 29.11%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Edwards Lifesciences (EW) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Edwards Lifesciences (EW) is $1.79B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Edwards Lifesciences (EW) have?

Edwards Lifesciences (EW) has a total debt of $706.7M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$2.97B.

Take Your Investments to a Whole New Level